Battery Ventures completed the acquisition of LI-COR Biosciences.

Battery Ventures, a global, technology focused investment firm, completed the acquisition of LI-COR Biosciences, a company that makes highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research and therapeutics development. Financial terms were not disclosed. “Partnering with Battery, a well-capitalized firm with an extensive history of backing innovative analytical-instrument businesses, is the logical evolution for LI-COR. We could not be more thrilled to leverage Battery’s capital, network and industry expertise to continue to drive our growth in this dynamic industry environment,” Greg Biggs, LI-COR CEO.